Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (932)	12/5/2001 11:51:36 PM
From: tuck	Read Replies (1) \| Respond to of 1784

It will be interesting to see if any of CRL's new shareholders decide to flip; Trickle would like another shot at it in the 20s . . . >>WILMINGTON, Mass.--(BW HealthWire)--Dec. 5, 2001--Charles River Laboratories International, Inc. (CRL:NYSE) announced today that the lead investor group in its September 1999 management-led leveraged buy-out transaction, Credit Suisse First Boston's DLJ Merchant Banking Group (DLJMB), has distributed to the limited partners in its private equity funds approximately 1.9 million shares of Charles River's common stock. On November 8, 2001, DLJMB also distributed 1.9 million CRL shares to these investors. Prior to today's distribution, DLJMB's private equity funds held approximately 15% of Charles River's outstanding common shares. Following this distribution, the DLJMB funds will hold approximately 4.7 million shares or 11% of the Company's outstanding common stock. James C. Foster, Chairman & CEO of Charles River, commented: ``This stock distribution is consistent with the significant growth and progress of Charles River over the past two years. DLJMB's distribution of largely unrestricted shares to their private equity investors should broaden our investor base, further increase the ''float`` in our stock, and significantly reduce the ''overhang`` resulting from DLJMB's substantial restricted position in the Company. The diverse group of investors who will receive shares in this distribution includes, among others, pension funds and large institutional investors. To be clear, this is not a new issuance of shares, but rather a transfer of existing shares of our common stock among investors. As a result, there is no increase in our shares outstanding, no registration of new securities with the SEC, and no EPS impact.''<< snip Cheers, Tuck